The landscape of immuno-oncology and precision medicine is undergoing a seismic shift. Gone are the days when a single biomarker could dictate the entire trajectory of...
In the high-speed world of modern molecular biology, we are moving past the simple era of just identifying genetic mutations. Scientists are no longer satisfied with...
The landscape of genomic medicine is undergoing a historic shift. As of April 2026, the CRISPR/Cas9 system has firmly established itself as the world’s most versatile...
